FDA Inspection 1173100 — Department of Defense - Navy

Department of Defense - Navy — FEI 3002809463

The FDA completed an inspection of Department of Defense - Navy on June 16, 2022 in Guantanamo Bay. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 16, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Guantanamo Bay (Cuba)